Market Cap
$44.44 Billion
USD as of July 1, 2024
Company | Market Cap (USD) |
---|---|
![]() |
$622.07 B |
![]() |
$121.36 B |
![]() |
$115.11 B |
![]() |
$95.75 B |
Marinomed Biotech AG | $75.67 B |
Company | Market Cap (USD) |
---|---|
![]() |
$808.65 B |
![]() |
$622.07 B |
![]() |
$450.89 B |
![]() |
$350.63 B |
![]() |
$318.75 B |
Top 1-year algo backtest: +207.50%
$10,000 in July 2023 would now be $30,750 by following this algorithm daily at market close.
Boost your investing & swing trading... Now!
Try Disfold DeepFinance FREE
Moderna, Inc. is a biotechnology company, specialized in vaccine technology based on messenger RNA. It is notably famous for producing one of the first vaccines against Covid-19, and it is also developing and patenting other vaccine candidates for seasonal flu, HIV, the Nipah virus, and a second COVID-19 vaccine.
Moderna, Inc. has the following listings and related stock indices.
Stock: NASDAQ: MRNA
Stock: BMV: MRNA
Stock: Bovespa: M1RN34
Stock: FSX: 0QF
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.